Thomas W. Ross Sr. has bought stock on 2 days since Mar 2020
Director at Bausch + Lomb Corporation, and 1 other company
SEC CIK 0001669396 · Filings on SEC.gov ↗
Thomas W. Ross Sr.'s record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Companies
Every filing
2 filings since Mar 2020, newest first
About Thomas W. Ross Sr.
Thomas W. Ross, Sr. is a seasoned corporate director serving as Lead Independent Director at Bausch + Lomb Corporation (BLCO) since 2022, and was appointed Chair of the Board following Joseph C. Papa's departure as chair.( He has demonstrated leadership in senior management positions, with extensive experience in corporate governance and complex legal knowledge, as highlighted in Bausch + Lomb's SEC filings.( Ross owns 60,391 shares in BLCO and 161,516 shares in Bausch Health Companies Inc. (BHC), reflecting his ongoing commitment to the eye health sector.(
Ross recently purchased 4,500 shares of BLCO on March 3, 2026, bringing his total holdings to 69,391 shares, amid a trend of insider buying at the company.( His board service includes strong attendance records, such as 7/8 Board meetings and full participation in Audit and Risk (8/8) and Science and Technology (4/4) committees in 2024.( Recommended by parent company BHC, Ross contributes to strategic oversight at the global eye health firm focused on vision care products and pharmaceuticals.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.